MoonLake Immunotherapeutics (MLTX) Earnings (2020 - 2026)
MoonLake Immunotherapeutics (MLTX) earnings from Sep 30, 2020 to Mar 31, 2026. The TTM MoonLake Immunotherapeutics (MLTX) earnings is -$257M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
MoonLake Immunotherapeutics (MLTX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +77.04% |
| 3 Years TTM | +81.37% |
| 5 Years TTM | +402.80% |
| All Time TTM | +127.51% |
Annual Earnings change of MoonLake Immunotherapeutics (MLTX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$70M | -69.33% |
| 2025 | -$227M | +91.12% |
| 2024 | -$119M | +230.30% |
| 2023 | -$36M | -27.94% |
| 2022 | -$50M | +1000.66% |
| 2021 | -$4.54M | N/A |
| 2020 | $0 | N/A |